Most people with diabetes develop severe complications of the autonomic nervous system; yet, the underlying causes of many diabetic-induced dysautonomias are poorly understood. Here we explore the idea that these dysautonomias results, in part, from a defect in synaptic transmission. To test this idea, we investigated cultured sympathetic neurons and show that hyperglycemia inactivates nAChRs through a mechanism involving an elevation in reactive oxygen species and an interaction with highly conserved cysteine residues located near the intracellular mouth of the nAChR channel. Consistent with this, we show that diabetic mice have depressed ganglionic transmission and reduced sympathetic reflexes, whereas diabetic mice expressing mutant postsynaptic nAChRs that lack the conserved cysteine residues on the a3 subunit have normal synaptic transmission in sympathetic ganglia and normal sympathetic reflexes. Our work suggests a new model for diabetic-induced dysautonomias and identifies ganglionic nAChRs as targets of hyperglycemia-induced downstream signals.
INTRODUCTION
The autonomic nervous system controls homeostasis through several intricate neural circuits, including nuclei in the hypothalamus and brainstem, cholinergic preganglionic neurons in the spinal cord, peripheral neurons in sympathetic and parasympathetic ganglia, and peripheral feedback from hormones and mechano-, chemo-, and thermosensory nerves. Diseases that disturb the function of these circuits produce dysautonomia or autonomic insufficiency (Low, 2002) , a heterogeneous disorder encompassing a wide range of abnormalities and unique syndromes that adversely affect the quality of life and shorten life expectancy (Freeman, 2005) . Most people with diabetes develop autonomic neuropathies or dysautonomias (Vinik et al., 2003; Dyck et al., 1993) . Symptoms range in severity and include cardiac arrhythmias, orthostatic hypotension, gastrointestinal abnormalities, and poor control of the circulation. Diabetic cardiovascular dysautonomia is among the most common and troubling because it causes abnormalities in heart rate and central and peripheral vascular dynamics; as a result, people with diabetes have an increased incidence of asymptomatic ischemia and a predisposition to malignant arrhythmogenesis and sudden cardiac death (Vinik and Ziegler, 2007; Duby et al., 2004) .
Clinically, diabetic autonomic neuropathies or dysautonomias usually become apparent in patients who have had diabetes for several years, and the syndrome is generally thought of as a progressive, late-stage complication of diabetes, although the underlying mechanisms that lead to the progression of this complication are poorly understood. A current hypothesis is that diabetic autonomic neuropathy is a disease of sympathetic nerve endings (Schmidt, 2002) . Support for this comes from observations that in the prevertebral superior mesenteric and celiac ganglia of patients with diabetes many sympathetic nerve endings are significantly enlarged and appear dystrophic (Schmidt, 1996) . On the other hand, there are no structural abnormalities in the paravertebral ganglia that regulate the cardiovascular system (Schmidt et al., 2008) , suggesting that diabetic cardiovascular dysautonomia results from a functional rather than structural defect. Although seldom considered, one cause for dysautonomias in diabetics could be a defect in synaptic transmission in autonomic ganglia.
Synapses in autonomic ganglia are the last step in the chain linking the integrative activity of the CNS to tissues and organs in the periphery. Normally, synaptic transmission in autonomic ganglia is strong and stable; however, if ganglionic synapses malfunction due to some disease process, this vital link between the CNS and the periphery becomes disrupted and dysautonomias ensue. A good example of such a disease is autoimmune autonomic ganglionopathies (AAG), a rare autoimmune disease that produces dysautonomias by disrupting the function of ganglionic a3-containing nAChRs (Vernino et al., 2000 (Vernino et al., , 2009 Klein et al., 2003) .
Here we show that hyperglycemia causes a defect in synaptic transmission in sympathetic ganglia. We go on to show that this synaptic defect results from hyperglycemia's effect on postsynaptic receptor function and that diabetic-induced dysautonomias can be reduced when the postsynaptic nAChRs are protected from these detrimental effects of hyperglycemia.
RESULTS

Hyperglycemia Depresses Synaptic Transmission in Sympathetic Ganglia
To test whether hyperglycemia causes a synaptic defect in sympathetic ganglia, we made neonatal and young adult mice diabetic by injecting them with streptozotocin (STZ; 60 mg/kg i.p.), a drug that destroys insulin-producing pancreatic beta cells (Lenzen, 2008; Junod et al., 1969) . Two to three days after STZ injection, blood glucose concentrations in 26 of 30 of these STZ-treated mice increased from 5-7 mM to 22-30 mM and remained above 25 mM for at least an additional 3 months.
To measure synaptic transmission in sympathetic ganglia, we stimulated the preganglionic nerve and used intracellular electrodes to record excitatory postsynaptic potentials (EPSPs) on postsynaptic sympathetic neurons in intact superior cervical ganglia. In ganglia from control mice, a maximal stimulus to the preganglionic nerve evoked large suprathreshold EPSPs that increase in magnitude over time (Figures 1A and 1B) . In contrast, the nerve-evoked EPSPs were significantly depressed on sympathetic neurons in ganglia from diabetic mice as early as 1 week after the onset of diabetes ( Figures 1A-1C) , and the depression became more severe over time ( Figure 1C ). The depression in synaptic transmission was similar in mice injected with STZ as neonates and in those injected with STZ as young adults. To rule out some unanticipated action of STZ on synaptic transmission, we exogenously supplied insulin through a slow-release pellet (2 U/24 hr/pellet) to mice at the time of STZ treatment; the nerve-evoked EPSPs (1216.36 mV*s ± 246.37, n = 11) in the SCG of these mice were not significantly different from those in ganglia of untreated, aged-matched control mice (1136.855 ± 128.7004, n = 25; p > 0.2) . These results show that diabetes severely depresses synaptic transmission in sympathetic ganglia.
Dysautonomias
Next, to determine whether the depression in synaptic transmission in sympathetic ganglia of diabetic mice correlates with a reduction in sympathetic nerve activity, we investigated noninvasively two end points of sympathetic nerve activity: tonic sympathetic drive on heart rate and thermoregulation (Bachman et al., 2002; Axelsson, 1971) . In addition, we also investigated these end points in a3 KO mice; SCG in a3 KO mice have no synaptic transmission (Krishnaswamy and Cooper, 2009; Rassadi et al., 2005; Xu et al., 1999) , and therefore these mice provide a measure of the maximum reduction in these sympathetic reflexes when ganglionic transmission is completely absent.
To measure the effects of tonic sympathetic nerve activity on heart rate, first we treated mice with atropine (1 mg/kg i.p.) to block muscarinic receptors, then we measured the difference in heart rate before and after treating mice with propranolol (1 mg/kg i.p.), a drug that blocks b-adrenergic receptors.
The sympathetic drive to the heart in both 5-week-old diabetic mice and a3-KO mice were considerably reduced compared to that in aged-match control mice ( Figure 1D ).
As a second measure of sympathetic function, we examined thermoregulation during cold exposure (Bachman et al., 2002) . (A) Nerve-evoked excitatory postsynaptic potentials (EPSPs) recorded intracellularly from sympathetic neurons from control mice at 1 week, 2 weeks, 1 month, and 3 months after injection with control buffer (upper row) or from mice 1 week, 2 week, 1 month, and 3 months after becoming diabetic as neonates (lower row). (B) Average integrated EPSP sizes recorded from sympathetic neurons in mice 1 week (n = 35 neurons), 2 weeks (n = 27), 1 month (n = 25), and 3 months (n = 58) after becoming diabetic. The EPSPs were normalized to the average integrated EPSP on control sympathetic neurons from 3-month-old mice. All values are the means ± SEM expressed as a percent of control. The solid lines are polynomial function. (C) Ratio of the average integrated EPSP sizes recorded from sympathetic neurons in diabetic mice to those in age-matched control mice at different times after the onset of diabetes. The depression of synaptic transmission becomes progressively more severe with time after onset. The solid line is a single exponential function. (D) Sympathetic drive to the heart measured as the difference between heart rates with atropine alone and atropine together with propanolol, in control mice (Control; n = 12 mice), diabetic mice (STZ; n = 15), mice treated simultaneously with STZ and insulin (STZ + Insulin; n = 5), and a3 KO mice (a3 KO; n = 10). Each bar is the mean bpm ± SEM. (E) Core body temperature measured for up to 3.5 hr at 4 C from a 3-month-old control mouse, a 3-month-old mouse made diabetic with STZ at 2 months, and a 2-month-old a3 KO mouse. (F) Core body temperature from control mice (Control; n = 6 mice), a3 KO mice (a3 KO; n = 6), mice made diabetic with STZ (STZ; n = 6), and mice treated simultaneously with STZ and insulin (STZ + Insulin; n = 3). Each bar is the mean ± SEM. ***p < 0.001 in (B), (D), and (F).
When 2-month-old control mice were placed at 4 C, their core body temperature remained constant for at least 2-3 hr. In contrast, when aged-matched a3 KO mice or diabetic mice were placed at 4 C, their core temperature dropped by several degrees within 2 hr ( Figures 1E and 1F ). Both the decrease in heart rate and the lack of thermoregulation in diabetic mice suggest that sympathetic nerve activity is low; although other factors may also contribute to the lack of thermoregulation in diabetic mice, these results are consistent with the depression in synaptic transmission in sympathetic ganglia.
Depressed Synaptic Transmission in Leptin (ob/ob) and Leptin Receptor (db/db) Mutant Mice To test further the idea that synaptic transmission is depressed in autonomic ganglia during diabetes, we investigated young adult (10-to 14-week-old) ob/ob and db/db mice, models for type 2 diabetes; these mice develop diabetes and hyperinsulinemia after the first postnatal month because of a disruption in leptin signaling (Chen et al., 1996; Zhang et al., 1994; Coleman, 1978) . Upon preganglionic nerve stimulation, the nerve-evoked EPSPs on sympathetic neurons in the SCG were considerably reduced in young adult diabetic ob/ob mice (45.17% ± 7.43% of EPSP size in aged-matched heterozygote +/ob mice; n = 24) and in adult diabetic db/db mice (51.41% ± 7.43% of EPSP size in aged-matched heterozygote +/db mice; n = 25); at the time of the experiment, all ob/ob and db/db homozygote mice had blood glucose levels >25 mM. Taken together with the results from STZ-treated diabetic mice, these data indicate that synaptic transmission in sympathetic ganglia is depressed in completely different diabetic models.
Hyperglycemia Inactivates Nicotinic Acetylcholine Receptors on Autonomic Neurons
To understand how hyperglycemia depresses synaptic transmission in diabetic mice, we investigated SCG neurons exposed to hyperglycemic conditions in culture. When neurons are exposed to hyperglycemic conditions, they increase their uptake of glucose, and this additional glucose alters several signaling pathways that could affect the function of sympathetic neurons (Tomlinson and Gardiner, 2008) , for example by elevating ROS. To test whether hyperglycemia elevates ROS in SCG neurons, we cultured neonatal SCG neurons in normal 5 mM glucose initially and then elevated glucose to 25 mM at 1 wk to mimic conditions in diabetes. Neonatal SCG neurons develop well in both 5 mM and 25 mM extracellular glucose ( Figure 2A ); in 25 mM glucose, these neurons had clear, centrally located nuclei, continued to extend long processes and grow in size, and synthesized tyrosine hydroxylase. To quantify neuron viability, we counted neurons in cultures before and after elevating glucose. One week after elevating glucose, the number of neurons was 97.5% ± 2.3% (mean ± SEM; n = 5 cultures) of the number before elevating glucose, and not significantly different (p > 0.2) from the number in sister cultures left in 5 mM glucose throughout (>99.4% ± 0.01% [mean ± SEM; n = 5 cultures]).
To determine relative changes in ROS levels in neurons when exposed to high glucose, we used the ROS indicator dye CM-H 2 DCFDA, or in some cases, we immunostained neurons for protein adducts of 4-hydroxy-2-nonenal (HNE), a major product of endogenous lipid peroxidation. Our results show that hyperglycemia caused both a mild elevation in ROS-induced fluorescence and an increase in HNE staining (Figures 2A and 2B) .
In a previous study, we showed that elevations in cytosolic ROS caused a use-dependent inactivation of nAChRs on (A) DIC and fluorescent images of neurons cultured in 5 mM glucose for 2 weeks or in 5 mM glucose for a week followed by 25 mM glucose for a week and loaded with CM-H 2 DCFDA for 1 hr. The bar graph shows the average DCFDA fluorescence intensity in arbitrary units for neurons cultured in 5 mM glucose for 2 weeks (n = 30 neurons) or in 5 mM glucose for a week followed by 25 mM glucose for a week (n = 30). (B) Fluorescent images of neurons cultured in 5 mM glucose for 2 weeks or in 5 mM glucose for a week followed by 25 mM glucose for a week and immunostained for tyrosine hydroxylase (TH, top) and protein adducts of 4-HNE (bottom). The graph shows the average HNE fluorescence intensity in arbitrary units for neurons cultured in 5 mM glucose for 2 weeks (n = 32 neurons) or in 5 mM glucose for a week followed by 25 mM glucose for a week (n = 32). (C) Currents evoked by a series of 1 s ACh (100 mM) applications delivered at 15 s intervals on neonatal mouse SCG neurons cultured in 5 mM glucose for the first week and then 1 week in 5 mM glucose (top), 1 week in 25 mM glucose (middle), or 1 week in 25 mM glucose and perfused intracellularly with a-lipoic acid and catalase (bottom). Every fourth trace is shown for clarity. (D) Ratio of the 30th ACh-evoked current to the first in the series (I 30 /I 1 ) for neurons cultured in 5 mM glucose for the first week and then 1 week in 5 mM glucose (n = 7 neurons), 1 week in 25 mM glucose (n = 14), 1 week in 25 mM glucose and perfused intracellularly with a-lipoic acid and catalase (n = 21), 1 week in 25 mM glucose together with insulin (30 nM) (n = 8), 3 days in 25 mM glucose together with aminoguanidine (AG, 250 mM) (n = 8). Each bar in (A), (B), and (D) is the mean ± SEM; ***p < 0.001. The scale bar in (A) and (B) is 20 mm. sympathetic neurons (Campanucci et al., 2008) . Given our results in Figures 2A and 2B that hyperglycemia causes a mild elevation in ROS, therefore we asked whether hyperglycemia also causes a use-dependent inactivation of nAChRs. To test this, we investigated nAChR function using whole-cell voltage clamp. Repeatedly applying ACh (100 mM for 1 s) to neurons maintained in 5 mM glucose (controls) at 15 s intervals for 5-10 min evoked large inward currents of constant amplitude ( Figure 2C ); the peak current amplitude of the 30th application (I 30 ) was close to that of the first (I 1 ) ( Figure 2D ). In contrast, repeatedly applying ACh at 15 s intervals to neurons exposed to 25 mM glucose caused a use-dependent rundown of the ACh-evoked currents ( Figure 2C) ; I 30 /I 1 was less than 30% ( Figure 2D ) and did not recover for as long as we could record from the neuron (at least 1 hr).
Hyperglycemia alters several downstream pathways in neurons (Tomlinson and Gardiner, 2008) and therefore it is conceivable that the mild elevation in ROS is not responsible for hyperglycemia's detrimental effects on nAChR function. To test whether ROS is involved, we treated neurons with the antioxidants a-lipoic acid (100 mM) and catalase (1000 units/ml). Neither a-lipoic acid nor catalase individually or together had any effect on the ACh-evoked currents in the control 5 mM glucose condition (data not shown). In contrast, a-lipoic acid and catalase prevented rundown of the ACh-evoked currents on neurons in high glucose conditions ( Figures 2C and 2D) . These results suggest that hyperglycemia acts through ROS to induce rundown of the ACh-evoked currents. This hyperglycemia-induced inactivation of nAChRs on SCG neurons likely accounts for the depression in synaptic transmission in SCG of diabetic mice.
Hyperglycemia-induced increase in intracellular ROS can lead to an accumulation of the highly reactive dicarbonyl, methylglyoxal (Yao et al., 2007; de Arriba et al., 2007) . To test whether methylglyoxal had a role in the use-dependent inactivation of nAChRs, we treated neurons in high glucose cultures with the carbonyl scavenger, aminoguanidine (Hammes et al., 1991; Webster et al., 2005) , when we elevated glucose from 5 mM to 25 mM. We found that aminoguanidine (100-250 mM for 1-3 days) did not prevent the hyperglycemia-induced rundown of the ACh-evoked currents ( Figure 2D ). These results suggest that high glucose does not exert its effect through highly reactive dicarbonyls.
In STZ-treated diabetic mice, circulating insulin levels are extremely low, whereas in mice with a disruption in leptin signaling insulin levels are high; however, synaptic transmission in SCG is depressed in both models. This indicates that the defect in synaptic transmission does not correlate with the circulating levels of insulin. Nonetheless, we investigated whether insulin might prevent the rundown of the ACh-evoked currents on cultured SCG neurons in hyperglycemic conditions. Our results indicate that adding insulin (0.5À30 nM) exogenously to cultured SCG neurons was unable to stabilize the ACh-evoked currents ( Figure 2D ).
ROS Attack Cys Residues in the M1-M2 Linker to Inactivate nAChRs
Next, we investigated the molecular mechanism that underlies the inactivation of nAChRs by hyperglycemia. From the amino acid sequence of a3 we noticed a highly conserved Cys residue, at position 239, located near the inner mouth of the receptor channel ( Figure 3A) . Since ROS is known to oxidize Cys residues, we asked whether hyperglycemia-induced ROS inactivates nAChRs by interacting with these Cys residues. Therefore, we mutated the Cys at position 239 in the a3 subunit to an Ala (a3
C239A
) and expressed it in cultured sympathetic neurons from a3 null (a3 KO) mice in hyperglycemic conditions. Sympathetic neurons from a3 KO mice do not have AChevoked currents (Rassadi et al., 2005) ; however, expressing either the WT or a3 C239A cDNA with adenoviral vectors rescued the ACh-evoked inward currents ( Figure 3B ), indicating that these a3 subunits can coassemble with endogenous b (and possibly other) subunits to form functional nAChRs. Equally relevant, we showed with repeated long pulses of ACh that the C239A mutation in a3 does not interfere with receptor desensitization or the recovery from desensitization ( Figure 3B ). (A more complete characterization of the a3
-containing nAChRs will be described elsewhere [A.K. and E.C., unpublished data]).
When a3 KO neurons were infected with vectors expressing the a3 WT and exposed to 25 mM glucose, the ACh-evoked currents ran down with repeated ACh application ( Figures 3C  and 3D ), similar to those on WT neurons. Interestingly, however, when a3 KO neurons were infected with vectors expressing the a3 C239A and exposed to 25 mM glucose, the ACh-evoked currents were stable ( Figures 3C and 3D ). These results indicate that inactivation of the receptor by hyperglycemia-induced ROS involves the Cys at position 239.
Are the Cys Residues in M1-M2 Responsible for the Depressed Synaptic Transmission in Diabetic Mice?
To test whether the C239A mutation in a3 prevents synapses in sympathetic ganglia from hyperglycemia-induced long-lasting depression, we infected a3 KO mice with adenoviral vectors expressing either a3 WT (Ada3/Syn), a3 C239A (Ada3 C239A /Syn), or control GFP (AdGFP/Syn), and 1 day later we either injected them with STZ or control citrate buffer. a3 KO mice have no synaptic transmission in the SCG; however, when we infected them with a3 WT or a3
C239A
, we rescued the nerve-evoked EPSPs (see also Krishnaswamy and Cooper, 2009 ). The nerve-evoked EPSPs in SCG of mice infected with a3 C239A were comparable to those infected with a3 WT or those in control WT mice (Figure 4A) . In a3 KO mice infected with a3 WT and made diabetic with STZ, the nerve-evoked EPSPs in SCG were considerably reduced 2 weeks after the onset of diabetes ( Figures 4B and  4C ), similar to the nerve-evoked EPSPs on sympathetic neurons in SCG of diabetic WT mice. In contrast, in a3 KO mice infected with a3
C239A and made diabetic with STZ, the nerve-evoked EPSPs in the SCG were not significantly different from those in nondiabetic WT mice ( Figures 4B and 4C ). These results indicate that Cys residues in the M1-M2 linker are responsible for the longlasting synaptic depression in autonomic ganglia of diabetic mice.
Cys Residues in the M1-M2 Linker of nAChRs Underlie Reduced Sympathetic Reflexes in Diabetic Mice
If the reduced sympathetic reflexes in diabetic mice resulted from a depression in synaptic transmission in sympathetic ganglia, then diabetic a3 KO mice infected with a3 C239A should have normal sympathetic reflexes. To test this, we infected diabetic a3 KO mice with either a3 WT or a3 C239A and measured the tonic sympathetic drive to the heart and thermoregulation as above. In diabetic a3 KO mice infected with a3 WT , the sympathetic drive to the heart was reduced similar to that in WT diabetic mice. On the other hand, in diabetic a3 KO mice infected with a3 C239A , the sympathetic drive to the heart was not reduced and was not significantly different from that in nondiabetic WT mice ( Figure 4D ). Furthermore, when placed at 4 C, the core body temperature of diabetic a3 KO mice infected with a3 WT dropped by several degrees within 2 hr, similar to diabetic WT mice, whereas when diabetic a3 KO mice infected with a3
C239A were placed at 4 C their core body temperature remained constant for at least 2-3 hr, similar to that for nondiabetic WT mice ( Figure 4E ).
DISCUSSION
Our work provides a model for the cause of diabetic-induced dysautonomias. We show that an early step leading to dysautonomias in diabetes is a depression of ganglionic synaptic transmission triggered by events downstream of hyperglycemia. Our results demonstrate that diabetes induces a depression in synaptic transmission in autonomic ganglia by elevating ROS and inactivating a3-containing postsynaptic nAChRs. This synaptic depression is apparent as early as 1 week after the onset of diabetes and becomes more severe over time. Because these nicotinic synapses in autonomic ganglia form a vital link between the integrative activities of the CNS and peripheral autonomic effector mechanisms, it is likely that most dysautonomias in diabetics are caused by this disruption of ganglionic transmission.
Hyperglycemia is known to elevate ROS in peripheral neurons, although the source of this hyperglycemia-induced ROS is not fully understood (Tomlinson and Gardiner, 2008) . Our results show that if we treat cultured sympathetic neurons with antioxidants, we can prevent the hyperglycemia-induced rundown of ACh-evoked currents. This suggests that the hyperglycemiainduced increase in cytosolic ROS mediates the rundown of the ACh-evoked currents on cultured sympathetic neurons by inactivating nAChRs.
One of the consequences of increased intracellular ROS in diabetes is accumulation of the highly reactive dicarbonyl, methylglyoxal. We find, however, that treating cultures with the carbonyl scavenger aminoguanidine did not prevent the hyperglycemia-induced rundown of the ACh-evoked currents. These results suggest that high glucose does not exert its effect on nAChRs through highly reactive dicarbonyls.
We have not determined how ROS inactivates the receptors, but our experiments expressing mutant a3 C239A in a3 KO neurons demonstrate that the conserved Cys residue located near the cytoplasmic mouth of the channel is essential for the use-dependent inactivation by hyperglycemia-induced ROS. It is likely that these conserved Cys residues form a ring near Each bar is the mean I 30 /I 1 ± SEM. ***p < 0.001.
Neuron
Hyperglycemia Inactivates Neuronal nAChRs the inner mouth of the receptor's pore. Our results suggest that a disruption of this Cys ring prevents the receptor from entering the inactivated state. Consistent with this idea, muscle nAChRs do not have this Cys ring and are not inactivated by elevated ROS (Campanucci et al., 2008) . Whether this Cys ring has other roles in receptor function is not clear. It does not appear to be important for surface expression of a3-containing nAChRs. Nor does it have an obvious role in receptor desensitization or recovery from desensitization. One possibility is that these Cys act to protect neurons from overstimulation when the neuron is under oxidative stress, perhaps during some pathological event, or when the neurons are transiently deprived of growth factors (Campanucci et al., 2008) . Interestingly, this residue is conserved in a4 and b2 nAChR subunits, two subunits widely expressed in the CNS, suggesting that nAChRs expressed on central neurons would be similarly inactivated by mild elevations in ROS.
In the STZ-treated diabetic mouse model, insulin is also extremely low; this raises the possibility that the depression of synaptic transmission results from low insulin as well as, or instead of, high glucose. We think this unlikely because treating cultures with insulin and high glucose did not prevent the rundown of ACh-evoked currents. Furthermore, ob/ob and db/db mice are both hyperglycemic and hyperinsulinemic at the ages used for our experiments (Chen et al., 1996; Zhang et al., 1994 ), yet synaptic transmission in the SCG of these mice was also significantly depressed. Since the common symptom among ob/ob, db/db, and STZ-treated mice is hyperglycemia, these results, taken together, add good evidence that it is hyperglycemia, and not low insulin, that depresses synaptic transmission in sympathetic ganglia of STZ-treated diabetic mice.
Furthermore, we show that most, if not all, of the depression in synaptic transmission in SCG of diabetic mice is due to inactivation of postsynaptic a3-containing nAChRs because we could prevent the depression by expressing a3
C239A
-containing nAChRs in diabetic a3 KO mice. In addition, we demonstrate with two separate examples, tonic sympathetic drive of the heart and thermoregulation, that sympathetic nerve-dependent reflexes are reduced when ganglionic transmission is depressed in diabetic mice, but normal in diabetic a3 C239A -expressing mice. These results provide a direct correlation between the inactivation of postsynaptic nAChRs and reduced sympathetic nerve function. a3-containing nAChRs are also present on mammalian parasympathetic neurons (Poth et al., 1997; Xu et al., 1999) . We did not examine the parasympathetic nervous system, but if hyperglycemia elevates ROS in parasympathetic neurons as it does in sympathetic neurons, we would expect that synaptic transmission in parasympathetic ganglia would be similarly depressed in diabetic animals.
Our results demonstrate that hyperglycemia also interferes with the function of a3-containing nAChRs through Cys residues on the a3 subunit. Since these Cys residues are conserved in human a3, b4, and b2, we think it reasonable that human ganglionic a3-containing nAChRs would be similarly inactivated by hyperglycemia-induced ROS. If this is the case, then it would suggest that some dysautonomias in people with diabetes may result from a disruption in ganglionic transmission and produce symptoms similar to dysautonomias in people with autoimmune autonomic ganglionopathies (Vernino et al., 2008 (Vernino et al., , 2009 ). 
EXPERIMENTAL PROCEDURES Animals
For most experiments, we used either outcrossed C57BL/6/J -CD + mice or heterozygote and homozygote Ob (B6.V-Lepob/J) and Db (BKS.Cg-Dock7 m +/+ Lepr db /J) mice (Jackson Laboratory, Bar Harbor, ME). For gene transfer experiments, we used outbred a3 KO mice, as described previously (Krishnaswamy and Cooper, 2009) . Most experiments were done with neonatal pups (P2-P21) and young adult (1-3 month) mice, except for those with Ob and Db mice who were 4-6 months old. For STZ injections, we withheld food from pups (P4-P7) for $2 hr, injected them with streptozotocin (STZ, 40-60 mg/kg); for older mice, we withheld food for 6 hr before STZ injection. One to two days after STZ injection, $80% of mice had blood glucose >22 mM (diabetic) that remained elevated. In some experiments, we implanted an insulin pellet under the skin (2 U/24 hr/implant, LinShin, Toronto) and injected them the next day with STZ (40-60 mg/kg).
Primary Cultures
Superior cervical ganglion (SCG) neurons were cultured from P1 to P3 mice (as previously described [McFarlane and Cooper, 1992; Campanucci et al., 2008] ) in media containing 5 mM glucose. To eliminate nonneuronal cells, cultures were treated with cytosine arabinoside (10 mM; Sigma, St. Louis, MO) from day 2 to 4. For high glucose experiments, 1-week-old cultures were switched to media containing 25 mM glucose for 1 week before measuring ACh-evoked currents. To rule out a direct effect of STZ on ACh-evoked currents, either neurons were cultured in 1 mM STZ for 1 week, or STZ (1 mM) was applied acutely to neurons while recording ACh-evoked currents; STZ had no direct effect on nAChRs. In addition, we cultured neurons in 0.5-30 nM insulin together with 25 mM glucose for 1 week; insulin did not prevent rundown of ACh-evoked currents.
Whole-Cell Recording
ACh-evoked currents were measured with whole-cell patch-clamp techniques as described previously (Campanucci et al., 2008) . Briefly, membrane currents were recorded with a VE-2 amplifier (Alembic Instruments, Montreal, Quebec, Canada) at room temperature, and the series resistance was reduced by 80%-98%; the currents were filtered and analyzed offline with Igor (WaveMetrics, Lake Oswego, OR) software. Recording electrodes were filled with a solution containing (in mM) 65 KF, 55 KAc, 5 NaCl, 0.2 CaCl 2 , 1 MgCl 2 , 10 EGTA, 2 MgATP, and 10 HEPES, and pH was adjusted to 7.2 with KOH. In some experiments, the a-lipoic acid (100 mM; pretreated with 1000 U/ml catalase for 1 hr at 37 C) was dissolved in intracellular solution. The cultures were perfused continuously at 1 ml/min with a solution containing (in mM) 140 NaCl, 5.4 KCl, 0.33 NaH 2 PO 4 , 0.44 KH 2 PO 4 , 2.8 CaCl 2 , 0.18 MgCl 2 , 10 HEPES, 5.6 glucose, 2 glutamine, and atropine (1 mM; Sigma). ACh (100 mM) was dissolved in the perfusion solution and applied to neurons by pressure ejection.
ROS Levels and Oxidative Stress
To measure protein adducts of 4-hydroxyl-2-nonenal (HNE), we fixed and permeabilized neurons with methanol (100%) at À20 C for 10 min, added rabbit anti 4-HNE (Alpha Diagnostics International; 1/500) and mouse anti-tyrosine hydroxylase (Chemicon; 1/400) overnight at 4 C, and then anti-rabbit Alexa 488 (Invitrogen; 1/1000) and anti-mouse rhodamine (Invitrogen; 1/400). Images were acquired with a Zeiss LSM 510 confocal microscope and analyzed with MetaMorph software (Universal Imaging, West Chester, PA).
To monitor ROS levels, we loaded neurons with the redox-sensitive dye CM-H 2 DCFDA and acquired DIC and fluorescent images (Campanucci et al., 2008) . On the DIC images, we defined regions of interest (neuronal cell body, excluding the nucleus) and transferred these to the fluorescent images of the same field and quantified mean fluorescent intensity (minus background) in 256 arbitrary units.
Recording from Sympathetic Neurons in Intact Ganglia
We recorded nerve-evoked EPSPs in SCGs with intracellular electrodes (Krishnaswamy and Cooper, 2009 ). Briefly, SCG were dissected rapidly from mice, pinned down in a recording chamber (1.5 ml volume), mounted on a fixed stage of a dissecting microscope, and the chamber was perfused continuously at 3-4 ml/min with a modified oxygenated Tyrode's (5 mM Ca 2+ ) solution at 36 C-37 C. The cervical sympathetic trunk was connected to a stimulator with a suction electrode and stimulated with brief voltage pulses. To quantify synaptic transmission, we stimulated the preganglionic nerve at 0.5-1 Hz for 1 min and integrated individual EPSPs. For suprathreshold EPSPs, we integrated the area bound by the spike and then subtracted it from the total area; the area under the AP usually accounted for <2% of the total area. Only neurons with membrane potentials greater than -45 mV were included in this study.
Heart Rate and Temperature Measurements
We used a MouseOX (STARR Life Science Corp, Oakmont, PA) heart monitor system to measure heart rate, and in some experiments, we also measured heart rates with a three-lead electrocardiogram. To measure thermoregulation, we placed mice in a cold room at 4 C and measured their body temperature using a small ($2 mm diameter) flexible rectal thermometer. Temperatureloss experiments were stopped at 3.5 hr.
Adenoviruses Neonatal (P0-P21) and young adult (P28-P42) a3 KO mice were infected with Ada3/Syn or Ada3 C239A /Syn adenovirus, as described previously (Krishnaswamy and Cooper, 2009 ).
Statistics
For differences in the mean fluorescent intensities, heart rates, and core temperature measurements, we used the Student's t test; for comparisons of the I 30 /I 1 ratios or EPSP areas, we used the nonparametric Mann-Whitney test.
All procedures for animal handling were performed according to the guidelines of the Canadian Council on Animal Care.
